BIOCEM S.A.

MOLECULAR PHARMING

In the statement, column 1, before line 1, Meristem Therapeutics, (France Corporation), 8 Rue Des Freres Lumiere, F-63000 Clermont-Ferrand, France should be inserted.;pharmaceutical preparations for the treatment of diseases linked to genetic dysfunction, protein deficiency; veterinary preparations for the treatment of feline immunodeficiency virus, rabies, lipid update insufficiency, obesity, in pets and wild animals; sanitary preparations for domestic and hospital use, namely, bactericides, anti-bacterial hand washes, antiseptics, germicides, and sanitizers; all-purpose disinfectants for medical instruments, premises and patients; dietetic substances for medical use, namely, food for medically restricted diets, diabetics, intravenous nutrition, babies;chemicals for use in the manufacture of diagnostic reagents, biomaterials for use in the biotechnological industry, for scientific use, for use in photography, and for agricultural use, namely, hormones, peptides, enzymes, proteins, growth hormones, growth regulators and inhibitors, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers; biomaterials for use in the manufacture of genetically modified organisms; and chemicals extracted or expressed by genetically modified organisms for use in the manufacture of therapeutics and cosmetics;MOLECULAR;